Outcome of Board Meeting

August 4, 2026 Listing Department Code: 531 335 BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department Code: ZYDUSWELL NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Outcome of Board Meeting Ref.: Unaudited financial results for the quarter ended on June 30, 2026, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir / Madam, The Board of Directors at their meeting held today i.e. August 4, 2026, based on the recommendations of the Audit Committee, approved the unaudited financial results for the quarter ended on June 30, 2026. In this regard, please find enclosed the following: 1. the unaudited financial results (standalone and consolidated) for the quarter ended on June 30, 2026, reviewed by the Audit Committee and taken on record by the Board of Directors, today i.e. August 4, 2026 pursuant to regulation 33 of the Listing Regulations. 2. the Limited Review Reports of Mukesh M. Shah & Co., Chartered Accountants and the Statutory Auditors of the Company certifying the limited review of the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on June 30, 2026 pursuant to regulation 33 of the Listing Regulations. The Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed until Thursday, August 6, 2026, and shall re-open for trading on and from Friday, August 7, 2026 for all the Directors and Designated Persons of the Company. The Board meeting commenced at 11:30 a.m. and concluded at 12:15 p.m. Please find the same in order. Thanking you, Yours faithfully, For, ZYDUS WELLNESS LIMITED NANDISH P. JOSHI COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: As above MUKESH M. SHAH & CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS The Board of Directors, Zydus Wellness Limited 1. We have reviewed the accompanying statement of Standalone Unaudited Financial Results of Zydus Wellness Limited ['the Company'], for the quarter ended on June 30, 2026 ['the Statement'] attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations"). 2. This statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting' ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Mukesh M. Shah & Co Chartered Accountants Firm Regn. No. 106625W Place: Ahmedabad Date: August 4, 2026 Mukesh M. Shah Partner UDIN: .2Go3 o '~0OTPEY Y2 .4 t4- Membership No. 030190 +91-79-2647 2000Icontact@mmsco.inIwww.mmsco.in 7th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015 Zydus Wellness Limited Registered office : Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Circle, wellness Sarl<hej-Gandhinagar Highway, Ahmedabad 382 481. ••~••I ~,f\ ........ , ,'to Tel. No. /+91-79) 4804 0000 Website: www.zvduswellness.com CIN: L15201Gl1994PLC023490 Statement of Standalone Unaudited Financial Results for the Quarter ended June 30, ·2026 , in Million Ouarter Ended Year Ended June March June March Sr. No. Part.iculars 30, 2026 31,2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 7 1 Income a Revenue from operations i Sales 1,353 1,114 1,303 5,284 ii Other operating income 177 212 106 537 Total Revenue from operations 1,530 1,326 1,409 5,821 b Other income 49 48 7 119 Total Income 1,579 1,374 1,416 5,940 2 Expenses a Cost of materials consumed 1,021 831 840 3,583 b Purchases of Stock-in-Trade 24 - C Changes in inventories of finished goocs, work-in-progress and stock-in-trade 3 20 (28) 59 d Employee benefits expense 153 143 174 568 e Finance costs 30 31 23 110 f Depreciation and amortisation expense 63 63 60 250 Q other expenses 211 171 269 825 h Net gain on foreign currency transacti_ons (37) (1) (55) Total Expenses 1 505 1 222 1 337 5 340 3 Profit before exceptional items and tax [1-2] 74 152 79 600 4 Exceptional items rRefer Not~ 51 112 5 Profit before tax (3-4 J 74 152 79 488 6 Tax expense a Current tax 2 1 8 40 b Deferred tax 17 18 25 72 Total tax expense 19 19 33 112 7 Net Profit [5-6] 55 133 46 376 8 Other Comprehensive InC"ome (OCI] a Items that will not be r~!assified to profit or loss Re-measurement loss on mst employment defined benefit plan 1 (2) (4) Income tax effect on abo\'~ items 1 Total Other Comprehensive Income (n,:,t of tax] - 1 12) ·(3) 9 Total Comprehensive Income (7+8] 55 134 44 373 Paid-up equity share rapital rFace Value { 2/-each] 636 636 636 636 Reserve excluding Revaluation Reserve [I.e. other equity] 39,690 Earnings per share rnot. annualised for the quarter] rRefer Note 41 a Basic r~l 0.17 0.42 0.14 1.18 b Diluted m 0.17 0.42 0.14 1.18 Notes: I. The above financial results were re.viewed by the Audit Committee and then approved by the Board of Directors at their meeting held on August 4, 2026. 2. The above financial results have been prepared in accordance with the Companies [Indian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securities and Exchange Board of India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. ). n,e Company operates in one segment, namely "Consumer Products". 4. The Board of directors at their meeting held on May 19, 2025 had approved the split / sub-division of equity shares from face value of { 10/-each to { 2/-each, fully paid-up. The same was effected on September 19, 2025. 5. Exceptional items comprise: Sr. Particulars , in Million No. Quarter Ended Year Ended June March June March 30, 2026 31, 2026 30,202.5 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Audited] Refer Note 7 - i. Expenses related to liquidation of Naturell (India) Private Limited [NIPL] with the Company on a - - [Showing first 8,000 characters — download PDF for full document]